Vioxx Reps Will Shift To Vaccines In Second Half Of 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck expects to redeploy its Vioxx sales force to vaccines in the second half of 2005, the company said Dec. 14 during its annual business review in Whitehouse Station, N.J